Literature DB >> 21641677

Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions.

Hee Jin Byun1, Jong In Yang2, Byoung Kook Kim3, Kwang Hyun Cho4.   

Abstract

BACKGROUND: The early diagnosis of acute cutaneous graft-versus-host disease (GVHD) is challenging as there are no specific features. Drug hypersensitivity reaction (DHR) is the most frequently encountered condition to differentiate from GVHD.
OBJECTIVES: We sought to investigate the clinical characteristics of acute cutaneous GVHD in comparison with DHR.
METHODS: A retrospective chart review was conducted for allogeneic hemopoietic-cell transplantation recipients with maculopapular rashes who had undergone hemopoietic-cell transplantation less than 100 days earlier. We analyzed the clinical characteristics of 22 patients with acute cutaneous GVHD in comparison with 17 patients with DHR.
RESULTS: Facial involvement was more frequent in the GVHD group (59%) than in the DHR group (24%). The difference was more significant when both the face and palms/soles were involved (36% in the GVHD group, no patients in the DHR group). Diarrhea was significantly more common in the GVHD group (73%) than in the DHR group (12%). The presence of both diarrhea and hyperbilirubinemia occurred only in the GVHD group (41%). In the GVHD group, the patients developed diarrhea and hyperbilirubinemia gradually with most patients exhibiting diarrhea and hyperbilirubinemia after 2 days. LIMITATIONS: A retrospective design, small number of patients, and single-center design are limitations.
CONCLUSIONS: Facial involvement, and moreover involvement of the face and palms/soles, suggests the diagnosis of GVHD versus DHR. The presence of diarrhea, and diarrhea accompanied by hyperbilirubinemia is thought to favor the diagnosis of GVHD. Rashes with more than 2 to 3 days of duration and not accompanied by diarrhea and hyperbilirubinemia are less likely to be GVHD.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641677     DOI: 10.1016/j.jaad.2010.07.042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.

Authors:  Marie-Charlotte Brüggen; Peter Petzelbauer; Hildegard Greinix; Emmanuel Contassot; Dragana Jankovic; Lars French; Gérard Socié; Werner Rabitsch; Zoya Kuzmina; Peter Kalhs; Robert Knobler; Georg Stingl; Georg Stary
Journal:  J Invest Dermatol       Date:  2014-11-18       Impact factor: 8.551

2.  Drugs as a Frequent Cause of Acute Rash in Patients after CD34+-Selected Peripheral Blood Stem Cell Transplantation.

Authors:  Skylar Klager; Mario E Lacouture; Margaret Hannum; Sean M Devlin; Molly Maloy; Melissa Pulitzer; Ann A Jakubowski; Alina Markova
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-12       Impact factor: 5.742

3.  In Vivo reflectance confocal microscopy of cutaneous acute graft-versus-host disease: concordance with histopathology and interobserver reproducibility of a glossary with representative images.

Authors:  I Saknite; M Gill; C Alessi-Fox; J P Zwerner; J S Lehman; M M Shinohara; R A Novoa; H Chen; M Byrne; S Gonzalez; M Ardigo; E R Tkaczyk
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-22       Impact factor: 9.228

4.  Establishing a standardized system for review and adjudication of chronic graft-vs-host disease data in accordance with the National Institutes Consensus criteria.

Authors:  Djamilia Dierov; Nicholas Webb; Samira Fatmi; Chamberlain Nwanne; Cristi Ciolino; Kara Mosesso; Jimmy Nieves; Miguel-Angel Perales; Susan E Prockop; Doris M Ponce
Journal:  Adv Cell Gene Ther       Date:  2019-05-02

Review 5.  [Cutaneous graft-versus-host disease].

Authors:  A Cho; U Just; R Knobler
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

6.  Inpatient Management of Mucocutaneous GVHD.

Authors:  Toral Vaidya; Christian Menzer; Doris M Ponce; Alina Markova
Journal:  Curr Dermatol Rep       Date:  2019-11-11

Review 7.  Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.

Authors:  Karla Strong Rodrigues; Carla Oliveira-Ribeiro; Silvia de Abreu Fiuza Gomes; Robert Knobler
Journal:  Am J Clin Dermatol       Date:  2018-02       Impact factor: 7.403

Review 8.  The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients.

Authors:  Alessandro Allegra; Eleonora Di Salvo; Marco Casciaro; Caterina Musolino; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Biomedicines       Date:  2020-12-22

9.  Incidence, Histopathological Features and Differential Diagnosis of Cutaneous Graft Versus Host Disease in Allogeneic Bone Marrow Transplantation.

Authors:  Uguray Payam Hacisalihoglu; Davut Sahin
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-03-17

10.  Follicular Graft Vs Host Reaction: A Rare Presentation.

Authors:  Deepak Vashisht; Rohit Kothari; Sukriti Baveja; Shekhar Neema; Prashant Sengupta; Sunmeet Sandhu
Journal:  Indian Dermatol Online J       Date:  2020-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.